Company / Revenue
GeneDx Holdings Corp. Revenue History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue
$427.5M
FY2025
5-year range
$202.6M / $427.5M
FY2021-FY2025
Trend
+40.0%
vs FY2024
Sector context
#119 of 150
Health Care
What the data says
GeneDx Holdings Corp.'s revenue of $428M is lower than 79% of companies in the Health Care sector (FY2025). Revenue has fluctuated over the past 7 years, ranging from $179M in FY2020 to $428M in FY2025.
Based on SEC 10-K filings.
$428M in FY2025 with a 5-year CAGR of +19.0%.
Improved from $203M to $428M over the past 2 years.
Health Care sector context is included.
Revenue over time
Growth rates
- 3-Year CAGR
- +22.1%
- 5-Year CAGR
- +19.0%
- 10-Year CAGR
- -
Sector benchmark
Bottom 21% in Health CareTop 79% of 150This company $427.5M Sector average $19.5B
▼
-97.8% below sector average
Key checks
Key Insights
- 5-year CAGR of +19.0%, indicating consistent growth.
- In FY2025, revenue increased 40.0% year-over-year.
- Ranks #119 out of 150 companies in the Health Care sector.
- Lowest revenue in the period was in FY2020.
Company context
Key Data Points
- Altman Z-Score -0.67 (distress zone, below 1.8 threshold)
- Negative profit margin: -17.1%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $427.5M | +40.0% |
| FY2024 | $305.4M | +50.8% |
| FY2023 | $202.6M | -13.7% |
| FY2022 | $234.7M | +10.6% |
| FY2021 | $212.2M | +18.3% |
| FY2020 | $179.3M | -8.6% |
| FY2019 | $196.2M | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026